- ICH GCP
- US Clinical Trials Registry
- Search trials
Søg i kliniske forsøg efter: Carrilizumab
I alt 426 resultater
-
Peking University People's HospitalJiangsu HengRui Medicine Co., Ltd.; Peking University Shougang HospitalTrukket tilbageProgression | Børnekræft | Virkning af stofferKina
-
Peking Union Medical College HospitalAfsluttetCholangiocarcinom | Hepatobiliær neoplasma | Galdevejskræft | BiomarkørKina
-
Zhejiang Cancer HospitalUkendt
-
Sun Yat-sen UniversityJiangsu Hengrui Pharmaceutical Co., Ltd.Ikke rekrutterer endnuMetastatisk galdevejskræft | Lokalt avanceret galdevejskræftKina
-
First Affiliated Hospital Xi'an Jiaotong UniversityIkke rekrutterer endnu
-
Fujian Medical University Union HospitalRekrutteringStrålebehandling | Immunterapi | Esophageal NeoplasmaKina
-
Cancer Institute and Hospital, Chinese Academy...Ikke rekrutterer endnu
-
Henan Provincial People's HospitalIkke rekrutterer endnu
-
Peking UniversityIkke rekrutterer endnu
-
Hebei Medical University Fourth HospitalRekruttering
-
Nanfang Hospital of Southern Medical UniversityRekrutteringNasopharyngealt karcinom | Oligometastase | StrålebehandlingKina
-
Tang-Du HospitalRekruttering
-
Henan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.Ikke rekrutterer endnu
-
Sun Yat-sen UniversityRekrutteringParanasal bihulekræft | Induktionskemoterapi | Camrelizumab | Kræft i næsehulen | Intensitetsmoduleret strålebehandling | Samtidig kemoterapiKina
-
Fudan UniversityRekruttering
-
The First Affiliated Hospital of Zhengzhou UniversityRekrutteringEsophageal Cancer af AJCC V8 StageKina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityIkke rekrutterer endnu
-
Jiangxi Provincial Cancer HospitalRekruttering
-
Huashan HospitalJiangsu HengRui Medicine Co., Ltd.; Shanghai Sunstem Biotechnology Co.,...RekrutteringTilbagevendende glioblastomKina
-
Peking University Third HospitalIkke rekrutterer endnu
-
The First Affiliated Hospital of Zhengzhou UniversityIkke rekrutterer endnuEsophageal pladecellekarcinom
-
Peking University People's HospitalJiangsu Hengrui Pharmaceutical Co., Ltd.Tilmelding efter invitationGermline BRCA-muteret HER2-negativ brystkræftKina
-
Sun Yat-sen UniversityRekrutteringPD-1 inhibitor | G-CSFKina
-
Guangdong Association of Clinical TrialsIkke rekrutterer endnuIkke-småcellet lungekræft
-
Beijing Sanbo Brain HospitalRekrutteringPrimært centralnervesystem lymfomKina
-
Guangdong Association of Clinical TrialsUkendt
-
wang shusenRekrutteringAvanceret HER2 negativ brystcarcinom HRD+brystkræftKina
-
Peking University Cancer Hospital & InstituteRekruttering
-
Nanfang Hospital of Southern Medical UniversityJiangsu HengRui Medicine Co., Ltd.RekrutteringHepatocellulært karcinomKina
-
Peking University First HospitalIkke rekrutterer endnuImmunterapi | SBRT | Stor tumor
-
The First Affiliated Hospital with Nanjing Medical...RekrutteringKolorektal neoplasmaKina
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityIkke rekrutterer endnuIkke-operabel galdeblærekræftKina
-
Peking Union Medical College HospitalRekrutteringEffekt og sikkerhed af Camrelizumab Plus S-1 vedligeholdelse efter førstelinjeinduktionskemoterapi til GCKina
-
Jiangsu HengRui Medicine Co., Ltd.Afsluttet
-
Peking University Cancer Hospital & InstituteRekruttering
-
Jiangsu HengRui Medicine Co., Ltd.Rekruttering
-
Tianjin Medical University Cancer Institute and...RekrutteringAvanceret HER2 negativ brystkarcinom | HRD+brystkræftKina
-
Jiangsu HengRui Medicine Co., Ltd.Afsluttet
-
Jiangsu HengRui Medicine Co., Ltd.Rekruttering
-
Sun Yat-sen UniversityRekrutteringNasopharyngealt karcinomKina
-
Huazhong University of Science and TechnologyThe First Affiliated Hospital of Nanchang UniversityRekrutteringLymfom | Tilbagefald/GentagelseKina
-
Tianjin Medical University Cancer Institute and...Ikke rekrutterer endnuEsophageal pladecellekarcinom | Progression til PD-1 antistofKina
-
Sun Yat-sen UniversityGuangdong Provincial People's Hospital; Affiliated Cancer Hospital & Institute... og andre samarbejdspartnereRekrutteringNasopharyngealt karcinomKina
-
Shanghai YingLi Pharmaceutical Co. Ltd.Ikke rekrutterer endnu
-
Zhejiang Cancer HospitalRekrutteringHjernemetastaser | NSCLC trin IV | ImmunterapiKina
-
Jiangsu HengRui Medicine Co., Ltd.Tilmelding efter invitation
-
Jiangsu HengRui Medicine Co., Ltd.Afsluttet
-
First Affiliated Hospital Xi'an Jiaotong UniversityRekrutteringAvanceret hepatocellulært karcinomKina
-
Jiangsu HengRui Medicine Co., Ltd.Aktiv, ikke rekrutterendeAdjuverende terapi hos patienter med hepatocellulært karcinom (HCC) med høj risiko for tilbagefald efter kurativ resektion eller ablationKina
-
Qian ChuJiangsu HengRui Medicine Co., Ltd.Rekruttering